Sat.Jan 27, 2024 - Fri.Feb 02, 2024

article thumbnail

Pharmacists' Patient Counseling Role

Pharmacy Times

Kristen Peterson, PharmD, BCOP, explores how pharmacists deliver comprehensive education, empower patients, manage side effects, and prioritize outcomes for multiple myeloma care, ensuring quality treatment understanding and adherence.

131
131
article thumbnail

COVID-19 Perceived as Less Serious Than Other Respiratory Illness Despite Global Spotlight

Drug Topics

Study findings that identified non-COVID respiratory illness as the most serious health issue among members of low- and middle-income countries provide policymakers with a valuable lens through which to understand and address public health concerns.

211
211
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacists’ Responses in Medical Emergencies Highlight Need for Provider Status

Pharmacy Times

On a flight home from ASHP Midyear in December, one pharmacist stepped up to the plate in a medical emergency.

149
149
article thumbnail

Healthcare sector cybersecurity retrospective and the year ahead

pharmaphorum

As cyberattacks continue to target the healthcare sector, it is crucial to look back at cybersecurity incidents from the past year and prepare for the challenges that lie ahead. This retrospective discusses the impact on patients, health systems, insurers, and vendors, and highlights the importance of cybersecurity measures in protecting sensitive healthcare information.

Insurance 118
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

2-Dose HPV Vaccine Postpartum Equally Effective as 3-Dose

Drug Topics

Approximately 330,000 cases of precancerous cervical dysplasia and 12,000 cases of cervical cancer in the United States per year are attributed to HPV.

Vaccines 181
article thumbnail

Texas Medical Board under pressure to define emergency exception to abortion ban

STAT

Amid ongoing uncertainty about when abortions are permissible in Texas, the state’s medical board is under growing pressure to issue guidance on what type of emergency qualifies for an exemption from the state’s abortion ban. Two high-profile abortion supporters filed a petition in January requesting the board define what would be grounds for a legal abortion, and their efforts are backed by activists from across the political divide.

145
145

More Trending

article thumbnail

Pfizer's layoff campaign ramps back up with dozens of SF-area cuts expected next month

Fierce Pharma

The start of the new year doesn’t seem to have dulled the zeal of Pfizer’s global cost-cutting campaign, which has already left hundreds of jobs in its wake. | Come mid-February, Pfizer will lay off some 52 employees at a facility in South San Francisco, according to a recent Worker Adjustment and Retraining Notification Act alert. The site is the former headquarters of Global Blood Therapeutics.

136
136
article thumbnail

Dexcom Submits New CGM For Non-Insulin Type 2 Diabetes for FDA Clearance

Drug Topics

Although continous glucose monitors (CGMs) have often been tailored to patients with type 1 diabetes, data elicited by these technologies add value to the management of type 2 diabetes by offering insights into patients’ unique responses to food, activity, medications, and more.

FDA 212
article thumbnail

Updated Covid vaccine has 54% effectiveness, new data suggest

STAT

New data released Thursday by the Centers for Disease Control and Prevention suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus. A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by the vaccine — called XBB.1.5 — and the JN.1 subvariant, which emerged after the vaccin

Vaccines 145
article thumbnail

Recurrent C difficile Infection Prevention: Efficacy and Administration of Fecal Microbiota Therapy

Pharmacy Times

Sharon Rimon, NP, shares insights on the rectal administration of fecal microbiota therapy, highlighting its efficacy, ease of adoption in clinical practice, and benefits for patients.

152
152
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA sets date for high-profile CAR-T adcomm for Bristol’s Abecma, J&J’s Carvykti

Fierce Pharma

Mark your calendars, oncology drug and CAR-T therapy developers. | Mark your calendars, oncology drug and CAR-T therapy developers. The FDA has decided on a date for a highly anticipated advisory committee meeting for Bristol Myers' Abecma and J&J's Carvykti.

FDA 130
article thumbnail

Slideshow: The Role of CGM in Diabetes Management During Pregnancy

Drug Topics

Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the impact of continuous glucose monitoring on pregnancy outcomes.

201
201
article thumbnail

FDA urged to move faster to fix pulse oximeters for darker-skinned patients

STAT

The Food and Drug Administration should move more quickly to ensure pulse oximeters — the ubiquitous devices used to measure blood oxygen — work well in all patients, should better inform clinicians about the devices’ shortcomings in patients with darker skin, and should recall versions that are particularly problematic, patients, researchers, and consumer advocates testified during a public meeting on Friday.

FDA 143
article thumbnail

Researchers Highlight Need for Greater Research Into RSV Among Older Adults, Vaccine Management

Pharmacy Times

The burden of RSV in the older population is becoming highly recognized as studies have assessed higher-risk individuals in industrialized and developing countries.

Vaccines 149
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Biogen abandons Aduhelm efforts, focuses on Eisai-partnered Leqembi and pipeline drugs

Fierce Pharma

More than two years after Aduhelm's controversial and ill-fated FDA accelerated approval, Bi | Biogen is discontinuing its first Alzheimer's disease therapy, Aduhelm, after walking a rocky path. The company is taking a $60 million charge, halting sales and terminating a confirmatory trial.

FDA 130
article thumbnail

Exploring Non-Pharmacological Interventions in Adolescents With Type 1 Diabetes

Drug Topics

Investigators found that the non-pharmacological interventions were significantly effective at improving HbA1c, quality of life, anxiety, and blood glucose.

209
209
article thumbnail

Some dementia patients might have reversible symptoms caused by cirrhosis, study says

STAT

The descent into dementia can feel like traversing a minefield, coming across new symptoms without the hope of a cure. But some dementia patients, even up to 10% of people diagnosed with the condition, might actually have undiagnosed liver disease and accompanying neurological problems, a new study in JAMA Open Network suggests. Most importantly, it’s possible their liver-related brain symptoms could be resolved with treatment.

145
145
article thumbnail

Study: Hydroxyurea Reduces Severe, Invasive Infections by 60% in Children with Sickle Cell Disease

Pharmacy Times

The findings suggest that further research on additional intervention methods and expanding access to hydroxyurea in Africa could benefit young patients with sickle cell disease.

139
139
article thumbnail

Insurer survey: No Surprises Act shielded patients from 10M surprise bills

Fierce Healthcare

Patients were protected from more than 10 million surprise medical bills thanks to reforms in the No Surprises Act, according to a new survey. | Patients were protected from more than 10 million surprise medical bills thanks to reforms in the No Surprises Act, according to a new survey.

Insurance 130
article thumbnail

Short Animated Videos on Social Media May Help Increase Knowledge of Vaccines

Drug Topics

Findings from a recent study showed that participants who watched a video discussing COVID-19 vaccination had significantly higher knowledge scores compared to those who did not watch it.

Vaccines 199
article thumbnail

STAT+: Years after a polarizing approval, Biogen walks away from Aduhelm

STAT

Biogen is giving up its ownership of Aduhelm , the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a tempestuous chapter in the company’s long history. Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday. Biogen will also terminate an ongoing clinical trial meant to prove the treatment’s benefits for patients in the early stages of Alzheimer’s

145
145
article thumbnail

Behavioral Psychotherapy, Antidepressants Yield Minimal Differences in Depression Treatment Coinciding With Heart Failure

Pharmacy Times

Investigators determined the effectiveness of behavioral activation psychotherapy versus antidepressant medication management for inpatients with heart failure and depression.

139
139
article thumbnail

Hospital-backed proposal would make insurers reveal prior auth denial rates

Fierce Healthcare

A recommendation on the 2024 Measures Under Consideration list, brought forward by the Federation of American Hospitals (FAH), would add a quality measure in the Medicare Advantage (MA) star rating | The Federation of American Hospitals is pushing CMS for the inclusion of a star ratings quality measure that shows how often insurers overturn or uphold prior authorization denials.

Insurance 127
article thumbnail

Diabetes Mortality Trends Remained Steady in the Americas Over 20-Year Period

Drug Topics

Although diabetes mortality rates were stable in the Americas over the past 2 decades, the actual number of diabetes-related deaths is rising.

187
187
article thumbnail

STAT+: Judge skeptical of arguments against Medicare drug price negotiation

STAT

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them. AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process.

144
144
article thumbnail

Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma

Pharmacy Times

The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.

136
136
article thumbnail

'Cybersecurity matter' forces Lurie Children's Hospital to take communications, MyChart offline

Fierce Healthcare

Lurie Children’s Hospital of Chicago has been working through a “cybersecurity matter” since Wednesday that has led the organization to take its phone, email and Epic MyChart systems offline, accor | Illinois' largest pediatric care provider said it took down its systems preemptively on Wednesday, leading to disruptions across its hospital and other locations.

Hospitals 125
article thumbnail

WuXi Biologics plays defense after US bill brands certain Chinese biopharmas as security threats

Fierce Pharma

New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days. | New legislation aimed at blocking a group of Chinese biopharma firms from tapping into U.S. federal funding has sent shares tumbling in recent days. WuXi Bio, for its part, says it's not affiliated with the military in China.

128
128
article thumbnail

Opinion: The emergency room is where the United States’ social problems come home to roost

STAT

From “ Legacy ” by Uché Blackstock, M.D., published by Viking, an imprint of Penguin Publishing Group, a division of Penguin Random House, LLC. Copyright © 2024 by Uché Blackstock, M.D. In the U.S., access to health care has long depended on insurance and a person’s ability to pay, with patients of color making up a disproportionate number of the under- or uninsured, as I have seen firsthand.

Insurance 145
article thumbnail

Considerations for RSV Prevention in Special Patient Populations

Pharmacy Times

Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.

article thumbnail

Merck is on the lookout for more opportunities within immunology

Pharmaceutical Technology

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.

144
144
article thumbnail

GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun

Fierce Pharma

Beaten to the punch by Pfizer in developing a vaccine for COVID, GSK has regained some of its lost luster as a vaccine powerhouse with its advancement of respiratory syncytial virus (RSV) shot Arex | GSK's RSV vaccine Arexvy generated $1.5 billion in sales in 2023 compared to $890 million for Pfizer's Abrysvo. But the British pharma major says that the successful launch represents just one round of a boxing match, and much is still to be decided, especially with Moderna expected to joi

Vaccines 125
article thumbnail

STAT+: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

STAT

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder. Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious.

145
145
article thumbnail

Understand the Differences in Carbidopa/Levodopa Formulations for Parkinson Disease

Pharmacy Times

Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.

139
139